Literature DB >> 455892

Rectal and oral absorption of methylprednisolone acetate.

D C Garg, J G Wagner, E Sakmar, D J Weidler, K S Albert.   

Abstract

Rectal absorption of methylprednisolone acetate and oral absorption of methylprednisolone and methylprednisolone acetate were investigated in a single-dose 3-way crossover study of 12 normal male volunteers. The median value of bioavailability (relative to oral dose) of methylprednisolone acetate based on unchanged methylprednisolone plasma levels was 14.2% after rectal administration, suggesting that the drug exerts its therapeutic effect topically rather than systemically. In contrast, the median of total radioactivity in urine (as a percentage of rectal dose) was 34.3% (range, 4.52% to 58.8%), suggesting partial bacterial metabolism in the rectum prior to absorption. Mean bioavailability (relative to oral administration of methylprednisolone acetate) of methylprednisolone after oral administration was 89.9%, indicating somewhat better systemic availability of the ester than the alcohol. The average apparent elimination rate constant for methylprednisolone after oral administration of both ester and alcohol was 0.290 hr-1, corresponding to a half-life of 2.39 hr.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 455892     DOI: 10.1002/cpt1979262232

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  7 in total

1.  Rectal pharmacokinetics of budesonide.

Authors:  K Dahlstrom; S Edsbacker; A Kallen
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

2.  Influence of route of administration on the pharmacokinetics of methylprednisolone.

Authors:  E J Antal; C E Wright; W R Gillespie; K S Albert
Journal:  J Pharmacokinet Biopharm       Date:  1983-12

Review 3.  Rectal drug administration: clinical pharmacokinetic considerations.

Authors:  A G de Boer; F Moolenaar; L G de Leede; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1982 Jul-Aug       Impact factor: 6.447

4.  High dose oral methylprednisolone in patients with rheumatoid arthritis: pharmacokinetics and clinical response.

Authors:  P J Hayball; D G Cosh; M J Ahern; D W Schultz; P J Roberts-Thomson
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

5.  Methylprednisolone pharmacokinetics after intravenous and oral administration.

Authors:  S M Al-Habet; H J Rogers
Journal:  Br J Clin Pharmacol       Date:  1989-03       Impact factor: 4.335

Review 6.  Emerging therapeutics in the management of COVID-19.

Authors:  Asim Kichloo; Michael Albosta; Akshay Kumar; Michael Aljadah; Mohamed Mohamed; Zain El-Amir; Farah Wani; Shakeel Jamal; Jagmeet Singh; Akif Kichloo
Journal:  World J Virol       Date:  2021-01-25

Review 7.  Role of Dexamethasone and Methylprednisolone Corticosteroids in Coronavirus Disease 2019 Hospitalized Patients: A Review.

Authors:  Jyoti Mehta; Rajan Rolta; Brij Bhushan Mehta; Neha Kaushik; Eun Ha Choi; Nagendra Kumar Kaushik
Journal:  Front Microbiol       Date:  2022-02-15       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.